|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00522184 |
|
Date of registration:
|
27/08/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study
|
|
Scientific title:
|
Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-Articular Steroid Injection in Acute Synovitis |
|
Date of first enrolment:
|
February 2005 |
|
Target sample size:
|
34 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00522184 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Christian H ROUX |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Rheumatology department, Nice |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- must be able to understand the information about the study
- diagnosis of rheumatoid arthritis for 6 month at least
- suffering for 2 weeks at least
- with evaluation of pain over 4/10
- with stable DMARDs treatment for three month at least
Exclusion Criteria:
- infection or surgery on the target joint
- treated with infliximab,adalimumab or anakinra
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Rheumatoid Arthritis
|
|
Intervention(s)
|
|
Procedure: intra-articular injection of etanercept
|
|
Procedure: intra-articular injection of steroid
|
|
Primary Outcome(s)
|
|
Pain
[Time Frame: every month during six month]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|